blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2171059

EP2171059 - RNAI INHIBITION OF ALPHA-ENAC EXPRESSION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  18.03.2011
Database last updated on 18.11.2024
Most recent event   Tooltip18.03.2011Application deemed to be withdrawnpublished on 20.04.2011  [2011/16]
Applicant(s)For all designated states
Novartis AG
Lichtstrasse 35
4056 Basel / CH
[2010/14]
Inventor(s)01 / VAN HEEKE, Gino
Novartis Horsham Research Centre Wimblehurst Road Horsham
West Sussex Sussex RH12 5AB / GB
02 / HICKMAN, Emma
Novartis Horsham Research Centre Wimblehurst Road Horsham
West Sussex Sussex RH12 5AB / GB
03 / DANAHAY, Henry Luke
Novartis Horsham Research Centre Wimblehurst Road Horsham
West Sussex Sussex RH12 5AB / GB
04 / TAN, Pamela
Kalte Marter 8
95326 Kulmbach / DE
05 / GEICK, Anke
Holderlin-Anlage 12
95447 Bayreuth / DE
06 / VORNLOCHER, Hans-Peter
Albert-Einstein-Ring 43a
95448 Bayreuth / DE
 [2010/14]
Representative(s)Spinner, David Richard
Novartis Pharma AG
Patent Department
4002 Basel / CH
[N/P]
Former [2010/14]Spinner, David Richard
Novartis Pharma AG Patent Department
4002 Basel / CH
Application number, filing date08761002.813.06.2008
[2010/14]
WO2008EP57476
Priority number, dateEP2007011037615.06.2007         Original published format: EP 07110376
EP2007011426513.08.2007         Original published format: EP 07114265
[2010/14]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008152131
Date:18.12.2008
Language:EN
[2008/51]
Type: A2 Application without search report 
No.:EP2171059
Date:07.04.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 18.12.2008 takes the place of the publication of the European patent application.
[2010/14]
Search report(s)International search report - published on:EP28.05.2009
ClassificationIPC:C12N15/11, A61K31/713
[2010/14]
CPC:
C12N15/1138 (EP,KR,US); A61K31/713 (EP,KR,US); A61K45/06 (US);
A61P11/00 (EP); A61P11/06 (EP); A61P13/12 (EP);
A61P3/12 (EP); A61P31/00 (EP); A61P31/12 (EP);
A61P35/00 (EP); A61P37/08 (EP); A61P43/00 (EP);
A61P9/00 (EP); A61P9/12 (EP); C12N2310/14 (EP,KR,US);
C12N2310/315 (KR,US); C12N2310/321 (EP,KR,US); C12N2310/322 (KR,US);
C12N2310/351 (KR,US); C12N2310/3513 (KR,US); C12N2310/3515 (KR,US);
C12N2310/3521 (KR) (-)
C-Set:
C12N2310/321, C12N2310/3521 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/14]
Extension statesAL15.01.2010
BA15.01.2010
RS15.01.2010
TitleGerman:RNAI-HEMMUNG DER ALPHA-ENAC-EXPRESSION[2010/14]
English:RNAI INHIBITION OF ALPHA-ENAC EXPRESSION[2010/14]
French:INHIBITION PAR ARNI DE L'EXPRESSION DU CANAL ALPHA-ENAC[2010/14]
Entry into regional phase15.01.2010National basic fee paid 
15.01.2010Designation fee(s) paid 
15.01.2010Examination fee paid 
Examination procedure15.01.2010Examination requested  [2010/14]
01.03.2010Amendment by applicant (claims and/or description)
15.04.2010Despatch of a communication from the examining division (Time limit: M06)
26.10.2010Application deemed to be withdrawn, date of legal effect  [2011/16]
29.11.2010Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2011/16]
Divisional application(s)EP10163496.2  / EP2224004
EP10163498.8  / EP2224005
EP10163499.6  / EP2223692
EP10163500.1  / EP2223693
EP10163501.9  / EP2223694
EP10163502.7  / EP2223695
Fees paidRenewal fee
11.06.2010Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]  - LI TIANBO ET AL, "RNA interference for alpha-ENaC inhibits rat lung fluid absorption in vivo.", AMERICAN JOURNAL OF PHYSIOLOGY. LUNG CELLULAR AND MOLECULAR PHYSIOLOGY APR 2006, (200604), vol. 290, no. 4, ISSN 1040-0605, pages L649 - L660, XP002509394 [X] 1-22 * the whole document *

DOI:   http://dx.doi.org/10.1152/AJPLUNG.00205.2005
 [A]  - GRIESENBACH UTA ET AL, "Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo", RESPIRATORY RESEARCH, BIOMED CENTRAL LTD., LONDON, GB, (20060215), vol. 7, no. 1, ISSN 1465-9921, page 26, XP021013304 [A] * the whole document *

DOI:   http://dx.doi.org/10.1186/1465-9921-7-26
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.